The Dixie Group, Inc.
The Dixie Group, Inc. (DXYN) Stock Competitors & Peer Comparison
See (DXYN) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DXYN | $0.35 | -1.41% | 4.9M | -0.70 | -$0.50 | N/A |
| RL | $371.24 | +0.03% | 22.5B | 25.27 | $14.70 | +0.98% |
| GIL | $58.57 | -2.12% | 9B | 22.80 | $2.57 | +1.58% |
| LEVI | $22.31 | -0.80% | 8.8B | 16.41 | $1.36 | +2.51% |
| VFC | $19.79 | -1.15% | 7.7B | 34.72 | $0.57 | +1.82% |
| PVH | $93.64 | -1.79% | 4.3B | 180.12 | $0.52 | +0.16% |
| KTB | $72.71 | -4.05% | 4B | 17.94 | $4.05 | +2.87% |
| ZGN | $11.96 | +0.00% | 3.2B | 26.58 | $0.45 | +1.18% |
| COLM | $60.26 | -3.15% | 3.2B | 18.60 | $3.24 | +1.98% |
| FIGS | $16.51 | +2.42% | 2.7B | 86.89 | $0.19 | N/A |
Stock Comparison
DXYN vs RL Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, RL has a market cap of 22.5B. Regarding current trading prices, DXYN is priced at $0.35, while RL trades at $371.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas RL's P/E ratio is 25.27. In terms of profitability, DXYN's ROE is -0.60%, compared to RL's ROE of +0.35%. Regarding short-term risk, DXYN is less volatile compared to RL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check RL's competition here
DXYN vs GIL Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, GIL has a market cap of 9B. Regarding current trading prices, DXYN is priced at $0.35, while GIL trades at $58.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas GIL's P/E ratio is 22.80. In terms of profitability, DXYN's ROE is -0.60%, compared to GIL's ROE of +0.20%. Regarding short-term risk, DXYN is less volatile compared to GIL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIL's competition here
DXYN vs LEVI Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, LEVI has a market cap of 8.8B. Regarding current trading prices, DXYN is priced at $0.35, while LEVI trades at $22.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas LEVI's P/E ratio is 16.41. In terms of profitability, DXYN's ROE is -0.60%, compared to LEVI's ROE of +0.28%. Regarding short-term risk, DXYN is less volatile compared to LEVI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LEVI's competition here
DXYN vs VFC Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, VFC has a market cap of 7.7B. Regarding current trading prices, DXYN is priced at $0.35, while VFC trades at $19.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas VFC's P/E ratio is 34.72. In terms of profitability, DXYN's ROE is -0.60%, compared to VFC's ROE of +0.15%. Regarding short-term risk, DXYN is less volatile compared to VFC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VFC's competition here
DXYN vs PVH Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, PVH has a market cap of 4.3B. Regarding current trading prices, DXYN is priced at $0.35, while PVH trades at $93.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas PVH's P/E ratio is 180.12. In terms of profitability, DXYN's ROE is -0.60%, compared to PVH's ROE of +0.01%. Regarding short-term risk, DXYN is less volatile compared to PVH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PVH's competition here
DXYN vs KTB Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, KTB has a market cap of 4B. Regarding current trading prices, DXYN is priced at $0.35, while KTB trades at $72.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas KTB's P/E ratio is 17.94. In terms of profitability, DXYN's ROE is -0.60%, compared to KTB's ROE of +0.45%. Regarding short-term risk, DXYN is less volatile compared to KTB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KTB's competition here
DXYN vs ZGN Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, ZGN has a market cap of 3.2B. Regarding current trading prices, DXYN is priced at $0.35, while ZGN trades at $11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas ZGN's P/E ratio is 26.58. In terms of profitability, DXYN's ROE is -0.60%, compared to ZGN's ROE of +0.10%. Regarding short-term risk, DXYN is less volatile compared to ZGN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check ZGN's competition here
DXYN vs COLM Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, COLM has a market cap of 3.2B. Regarding current trading prices, DXYN is priced at $0.35, while COLM trades at $60.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas COLM's P/E ratio is 18.60. In terms of profitability, DXYN's ROE is -0.60%, compared to COLM's ROE of +0.11%. Regarding short-term risk, DXYN is less volatile compared to COLM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check COLM's competition here
DXYN vs FIGS Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, FIGS has a market cap of 2.7B. Regarding current trading prices, DXYN is priced at $0.35, while FIGS trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas FIGS's P/E ratio is 86.89. In terms of profitability, DXYN's ROE is -0.60%, compared to FIGS's ROE of +0.08%. Regarding short-term risk, DXYN is less volatile compared to FIGS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check FIGS's competition here
DXYN vs UAA Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, UAA has a market cap of 2.6B. Regarding current trading prices, DXYN is priced at $0.35, while UAA trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas UAA's P/E ratio is -5.07. In terms of profitability, DXYN's ROE is -0.60%, compared to UAA's ROE of -0.29%. Regarding short-term risk, DXYN is less volatile compared to UAA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UAA's competition here
DXYN vs UA Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, UA has a market cap of 2.6B. Regarding current trading prices, DXYN is priced at $0.35, while UA trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas UA's P/E ratio is -4.91. In terms of profitability, DXYN's ROE is -0.60%, compared to UA's ROE of -0.29%. Regarding short-term risk, DXYN is less volatile compared to UA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UA's competition here
DXYN vs HBI Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, HBI has a market cap of 2.3B. Regarding current trading prices, DXYN is priced at $0.35, while HBI trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas HBI's P/E ratio is 5.53. In terms of profitability, DXYN's ROE is -0.60%, compared to HBI's ROE of +1.91%. Regarding short-term risk, DXYN is less volatile compared to HBI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check HBI's competition here
DXYN vs AIN Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, AIN has a market cap of 1.6B. Regarding current trading prices, DXYN is priced at $0.35, while AIN trades at $55.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas AIN's P/E ratio is -28.52. In terms of profitability, DXYN's ROE is -0.60%, compared to AIN's ROE of -0.07%. Regarding short-term risk, DXYN is less volatile compared to AIN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check AIN's competition here
DXYN vs GIII Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, GIII has a market cap of 1.3B. Regarding current trading prices, DXYN is priced at $0.35, while GIII trades at $31.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas GIII's P/E ratio is 20.77. In terms of profitability, DXYN's ROE is -0.60%, compared to GIII's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to GIII. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIII's competition here
DXYN vs GOOS Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, GOOS has a market cap of 1.1B. Regarding current trading prices, DXYN is priced at $0.35, while GOOS trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas GOOS's P/E ratio is 73.25. In terms of profitability, DXYN's ROE is -0.60%, compared to GOOS's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to GOOS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GOOS's competition here
DXYN vs OXM Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, OXM has a market cap of 664.9M. Regarding current trading prices, DXYN is priced at $0.35, while OXM trades at $44.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas OXM's P/E ratio is -24.01. In terms of profitability, DXYN's ROE is -0.60%, compared to OXM's ROE of -0.05%. Regarding short-term risk, DXYN is less volatile compared to OXM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check OXM's competition here
DXYN vs SGC Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, SGC has a market cap of 184.7M. Regarding current trading prices, DXYN is priced at $0.35, while SGC trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas SGC's P/E ratio is 26.73. In terms of profitability, DXYN's ROE is -0.60%, compared to SGC's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to SGC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SGC's competition here
DXYN vs LAKE Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, LAKE has a market cap of 98.9M. Regarding current trading prices, DXYN is priced at $0.35, while LAKE trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas LAKE's P/E ratio is -3.82. In terms of profitability, DXYN's ROE is -0.60%, compared to LAKE's ROE of -0.18%. Regarding short-term risk, DXYN is less volatile compared to LAKE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LAKE's competition here
DXYN vs FFFZ Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, FFFZ has a market cap of 68.8M. Regarding current trading prices, DXYN is priced at $0.35, while FFFZ trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas FFFZ's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.60%, compared to FFFZ's ROE of N/A. Regarding short-term risk, DXYN and FFFZ have similar daily volatility (0.00).Check FFFZ's competition here
DXYN vs UFI Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, UFI has a market cap of 67.6M. Regarding current trading prices, DXYN is priced at $0.35, while UFI trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas UFI's P/E ratio is -2.98. In terms of profitability, DXYN's ROE is -0.60%, compared to UFI's ROE of -0.23%. Regarding short-term risk, DXYN is less volatile compared to UFI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UFI's competition here
DXYN vs VNCE Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, VNCE has a market cap of 64M. Regarding current trading prices, DXYN is priced at $0.35, while VNCE trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas VNCE's P/E ratio is 9.80. In terms of profitability, DXYN's ROE is -0.60%, compared to VNCE's ROE of +0.13%. Regarding short-term risk, DXYN is less volatile compared to VNCE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VNCE's competition here
DXYN vs JRSH Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, JRSH has a market cap of 43.4M. Regarding current trading prices, DXYN is priced at $0.35, while JRSH trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas JRSH's P/E ratio is 24.43. In terms of profitability, DXYN's ROE is -0.60%, compared to JRSH's ROE of +0.03%. Regarding short-term risk, DXYN is less volatile compared to JRSH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JRSH's competition here
DXYN vs CULP Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, CULP has a market cap of 38.7M. Regarding current trading prices, DXYN is priced at $0.35, while CULP trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas CULP's P/E ratio is -3.82. In terms of profitability, DXYN's ROE is -0.60%, compared to CULP's ROE of -0.13%. Regarding short-term risk, DXYN is less volatile compared to CULP. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check CULP's competition here
DXYN vs JL Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, JL has a market cap of 24.1M. Regarding current trading prices, DXYN is priced at $0.35, while JL trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas JL's P/E ratio is 9.41. In terms of profitability, DXYN's ROE is -0.60%, compared to JL's ROE of +0.31%. Regarding short-term risk, DXYN is less volatile compared to JL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JL's competition here
DXYN vs LLL Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, LLL has a market cap of 10.8M. Regarding current trading prices, DXYN is priced at $0.35, while LLL trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas LLL's P/E ratio is -0.10. In terms of profitability, DXYN's ROE is -0.60%, compared to LLL's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to LLL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LLL's competition here
DXYN vs XELB Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, XELB has a market cap of 10.6M. Regarding current trading prices, DXYN is priced at $0.35, while XELB trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas XELB's P/E ratio is -0.44. In terms of profitability, DXYN's ROE is -0.60%, compared to XELB's ROE of -0.79%. Regarding short-term risk, DXYN is less volatile compared to XELB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check XELB's competition here
DXYN vs PMNT Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, PMNT has a market cap of 10.2M. Regarding current trading prices, DXYN is priced at $0.35, while PMNT trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas PMNT's P/E ratio is -0.44. In terms of profitability, DXYN's ROE is -0.60%, compared to PMNT's ROE of -10.56%. Regarding short-term risk, DXYN is less volatile compared to PMNT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PMNT's competition here
DXYN vs JXJT Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, JXJT has a market cap of 4.9M. Regarding current trading prices, DXYN is priced at $0.35, while JXJT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas JXJT's P/E ratio is 1.47. In terms of profitability, DXYN's ROE is -0.60%, compared to JXJT's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to JXJT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JXJT's competition here
DXYN vs DLA Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, DLA has a market cap of 4.1M. Regarding current trading prices, DXYN is priced at $0.35, while DLA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas DLA's P/E ratio is -0.06. In terms of profitability, DXYN's ROE is -0.60%, compared to DLA's ROE of -0.20%. Regarding short-term risk, DXYN is less volatile compared to DLA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check DLA's competition here
DXYN vs NCI Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, NCI has a market cap of 3.9M. Regarding current trading prices, DXYN is priced at $0.35, while NCI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas NCI's P/E ratio is 3.42. In terms of profitability, DXYN's ROE is -0.60%, compared to NCI's ROE of +0.02%. Regarding short-term risk, DXYN is less volatile compared to NCI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check NCI's competition here
DXYN vs PERY Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, PERY has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.35, while PERY trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas PERY's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.60%, compared to PERY's ROE of +0.15%. Regarding short-term risk, DXYN and PERY have similar daily volatility (0.00).Check PERY's competition here
DXYN vs SQBG Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, SQBG has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.35, while SQBG trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas SQBG's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.60%, compared to SQBG's ROE of -1.42%. Regarding short-term risk, DXYN is less volatile compared to SQBG. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SQBG's competition here
DXYN vs EVK Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, EVK has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.35, while EVK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas EVK's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.60%, compared to EVK's ROE of -0.00%. Regarding short-term risk, DXYN is less volatile compared to EVK. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check EVK's competition here
DXYN vs KBSF Comparison April 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 4.9M. In comparison, KBSF has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.35, while KBSF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.70, whereas KBSF's P/E ratio is -1.46. In terms of profitability, DXYN's ROE is -0.60%, compared to KBSF's ROE of -0.10%. Regarding short-term risk, DXYN is less volatile compared to KBSF. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KBSF's competition here